-
Mashup Score: 1Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020 - 3 day(s) ago
This model-based study using population-level cancer mortality data evaluates the association of prevention, screening, and treatment interventions with cumulative number of cancer deaths averted from 1975 to 2020 for breast, cervical, colorectal, lung, and prostate cancers.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 5Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020 - 3 day(s) ago
This model-based study using population-level cancer mortality data evaluates the association of prevention, screening, and treatment interventions with cumulative number of cancer deaths averted from 1975 to 2020 for breast, cervical, colorectal, lung, and prostate cancers.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet-
Cancer prevention and screening activities were the main contributors to reductions in mortality due to the most common cancers in the US over the past 45 years. https://t.co/NegdPEfHNw @CenterTobacco
-
-
Mashup Score: 0Long-Term Toxicity of Immune Checkpoint Inhibitors - 4 day(s) ago
This Viewpoint discusses the need to quantify the long-term adverse effects of immune checkpoint inhibitors, particularly immune-related adverse effects, which are not universally dose dependent, limiting the value of conventional adverse event grading systems.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet-
Most viewed in the last 7 days from @JAMAOnc: Viewpoint: The growing use of immune checkpoint inhibitors in cancer treatment brings significant therapeutic benefits but also long-term immune-related adverse effects. https://t.co/GjVdhBnSql https://t.co/IR0K0TtS4G
-
-
Mashup Score: 0
This randomized clinical trial evaluates the efficacy of hand cooling and compression in reducing the risk of chemotherapy-induced peripheral neuropathy in patients with breast cancer.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet-
Both hand cooling and compression were effective in preventing sensory chemotherapy-induced peripheral neuropathy during taxane-based chemotherapy. https://t.co/HHT7iAKvvw @mbreckwoldt https://t.co/u89tX2gQtl
-
-
Mashup Score: 0Novel Combination Immunotherapy and Clinical Activity in Patients With HPV-Associated Cancers - 7 day(s) ago
This nonrandomized clinical trial examines the clinical activity and adverse events of a novel combination treatment for advanced human papillomavirus–associated cancers.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet-
Most viewed in the last 7 days from @JAMAOnc: This study found the combination of PDS0101, PDS01ADC, and BA has an acceptable safety profile and showed promising clinical activity and OS outcomes in patients with advanced HPV-16–positive cancers. https://t.co/nLAlnk5KtZ https://t.co/zgp1kuKpyn
-
-
Mashup Score: 0Can Knowledge From Treating Chronic Myeloid Leukemia Inform Therapy of EGFR-Mutant Lung Adenocarcinoma? - 19 day(s) ago
This Viewpoint discusses how therapy of chronic myeloid leukemia can inform therapy of lung cancer.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet-
Viewpoint: Insights from treating chronic myeloid leukemia with tyrosine kinase inhibitors may inform EGFR-mutant lung adenocarcinoma therapy. https://t.co/Zn4wbUr8aJ https://t.co/3SkwJBy6Y2
-
-
Mashup Score: 0Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer - 19 day(s) ago
This 10-year follow-up analysis of the ShortHER randomized clinical trial evaluates the association of tumor-infiltrating lymphocytes with distant disease-free and overall survival among patients with ERBB2 (formerly HER2)–positive early breast cancer.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet-
Most viewed in the last 7 days from @JAMAOnc: Tumor-infiltrating lymphocytes can serve as a biomarker to identify patients with ERBB2-positive early breast cancer who may safely undergo de-escalated adjuvant therapy without compromising long-term SO. https://t.co/zkL7nixz8d https://t.co/CElCVkTbgH
-
-
Mashup Score: 1Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer - 24 day(s) ago
This 10-year follow-up analysis of the ShortHER randomized clinical trial evaluates the association of tumor-infiltrating lymphocytes with distant disease-free and overall survival among patients with ERBB2 (formerly HER2)–positive early breast cancer.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet-
Higher tumor-infiltrating lymphocytes (TILs) were strongly associated with improved overall survival in patients with ERBB2-positive early breast cancer. https://t.co/nCUSANFI2Z https://t.co/fKGTEPpGPn
-
-
Mashup Score: 9
This observational study reports on a comprehensive nationwide evaluation of rising gastroenteropancreatic neuroendocrine tumor incidence in the US from 2001 to 2020.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet-
The incidence of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in the US has increased over the past two decades, particularly in the appendix, pancreas, and small intestine. https://t.co/OEYymp60Rj https://t.co/whB2HiFBFA
-
-
Mashup Score: 23Biomarker-Directed Radiotherapy in Breast Cancer - 1 month(s) ago
This narrative review explores the potential of biomarker-directed personalized radiotherapy approaches.
Source: jamanetwork.comCategories: General Medicine News, Oncologists1Tweet-
Integrating molecular biomarkers into radiotherapy could revolutionize treatment strategies for breast cancer patients, improving patient outcomes and quality of life. https://t.co/1XMXgSBUsb https://t.co/J1dL2a7Gpt
-
Cancer prevention and screening activities were the main contributors to reductions in mortality due to the most common cancers in the US over the past 45 years. https://t.co/GUY9vtqErz @CenterTobacco https://t.co/mOEW0m5vSl